223 related articles for article (PubMed ID: 25962968)
1. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.
Bongiovanni L; D'Andrea A; Porcellato I; Ciccarelli A; Malatesta D; Romanucci M; Della Salda L; Mechelli L; Brachelente C
Vet Dermatol; 2015 Aug; 26(4):270-e59. PubMed ID: 25962968
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.
Han JI; Kim DY; Na KJ
Vet Pathol; 2010 Mar; 47(2):285-91. PubMed ID: 20139375
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal transition: immunohistochemical investigation of related molecules in canine cutaneous epithelial tumours.
Bongiovanni L; D'Andrea A; Romanucci M; Malatesta D; Candolini M; Salda LD; Mechelli L; Sforna M; Brachelente C
Vet Dermatol; 2013 Feb; 24(1):195-203.e42-3. PubMed ID: 23331698
[TBL] [Abstract][Full Text] [Related]
4. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
5. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
Roels S; Tilmant K; Ducatelle R
J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
[TBL] [Abstract][Full Text] [Related]
6. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
Pires I; Garcia A; Prada J; Queiroga FL
J Comp Pathol; 2010; 143(2-3):142-9. PubMed ID: 20207364
[TBL] [Abstract][Full Text] [Related]
7. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.
Sanders DS; Blessing K; Hassan GA; Bruton R; Marsden JR; Jankowski J
Mol Pathol; 1999 Jun; 52(3):151-7. PubMed ID: 10621837
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
[TBL] [Abstract][Full Text] [Related]
9. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
Cuitiño MC; Massone AR; Idiart JR
J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819
[TBL] [Abstract][Full Text] [Related]
10. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
[TBL] [Abstract][Full Text] [Related]
11. β-catenin in canine skin: immunohistochemical pattern of expression in normal skin and cutaneous epithelial tumours.
Bongiovanni L; Malatesta D; Brachelente C; D'Egidio S; Della Salda L
J Comp Pathol; 2011; 145(2-3):138-47. PubMed ID: 21388636
[TBL] [Abstract][Full Text] [Related]
12. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
Han JI; Kim Y; Kim DY; Na KJ
Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
[TBL] [Abstract][Full Text] [Related]
13. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
[TBL] [Abstract][Full Text] [Related]
14. Review of the comparative pathological and immunohistochemical features of human and canine cutaneous melanocytic neoplasms.
Contel IJ; Fonseca-Alves CE; Ferrari HF; Laufer-Amorim R; Xavier-Júnior JCC
J Comp Pathol; 2024 May; 211():26-35. PubMed ID: 38761560
[TBL] [Abstract][Full Text] [Related]
15. Congenital cutaneous melanoma in a dog.
Meyrer B; Bianchi SP; Pavarini SP; Gerardi DG
Vet Dermatol; 2017 Apr; 28(2):228-e56. PubMed ID: 27813258
[TBL] [Abstract][Full Text] [Related]
16. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
[TBL] [Abstract][Full Text] [Related]
17. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
Cangul IT; van Garderen E; van der Linde-Sipman JS; van den Ingh TS; Schalken JA
J Comp Pathol; 2001; 125(2-3):166-73. PubMed ID: 11578133
[TBL] [Abstract][Full Text] [Related]
18. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
19. FoxP3 and IDO in Canine Melanocytic Tumors.
Porcellato I; Brachelente C; De Paolis L; Menchetti L; Silvestri S; Sforna M; Vichi G; Iussich S; Mechelli L
Vet Pathol; 2019 Mar; 56(2):189-199. PubMed ID: 30381008
[TBL] [Abstract][Full Text] [Related]
20. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors.
Mukaratirwa S; Chikafa L; Dliwayo R; Moyo N
Vet Dermatol; 2006 Apr; 17(2):141-6. PubMed ID: 16515657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]